Micah Benson

Company: KSQ Therapeutics

Job title: Chief Scientific Officer

Seminars:

Driving Innovation in TIL Therapy with a Pipeline Update from KSQ Therapeutics 9:10 am

Showcasing recent clinical data on the efficacy and safety of KSQ Therapeutics’ engineered TIL therapies across multiple cancer types Exploring how gene-editing strategies are improving TIL function and persistence, with implications for more durable and effective patient outcomesRead more

day: Conference Day One AM

Fireside Chat: Clinical Data & Reflections on the Current State of TIL Therapies in the Clinic 9:30 am

Examining the latest clinical insights shaping TIL therapy to better understand the direction of innovation in the field Discussing real-world challenges and opportunities in TIL development to uncover practical strategies for accelerating progress Envisioning the future of TIL therapies through expert perspectives to inform more effective research and clinical decisionsRead more

day: Conference Day One AM